Skip to main content

Table 2 The associations between LDL-C, non-HDL-C and Apo B goal attainment and sex, in diabetics with very high ASCVD risk status, adjusting for various other factors in the models, were performed using multivariate logistic regressions

From: Sex disparity in the management and outcomes of dyslipidemia of diabetic patients in the Arabian Gulf: findings from the CEPHEUS study

Characteristic

LDL-C goal

Non-HDL-C goal

Apo B goal

aOR[95% CI]

P-value

aOR[95% CI]

P-value

aOR[95% CI]

P-value

Female

0.58 [0.40–0.86]

0.006

0.68 [0.46–0.99]

0.048

0.64 [0.44–0.92]

0.016

Age

1.01 [0.98–1.03]

0.217

1.01 [0.99–1.02]

0.558

1.00 [0.99–1.02]

0.587

BMI

1.00 [0.97–1.03]

0.734

1.00 [0.97–1.03]

0.984

1.00 [0.97–1.02]

0.860

Smoker

0.68 [0.41–1.12]

0.127

0.78 [0.47–1.30]

0.342

0.70 [0.43–1.13]

0.142

MetS

0.84 [0.57–1.23]

0.371

1.59 [1.06–2.39]

0.026

1.15 [0.78–1.68]

0.474

TG

0.86 [0.71–1.04]

0.127

0.16 [0.11–0.24]

< 0.001

0.30 [0.22–0.41]

< 0.001

LDL-C

1.00 [1.00–1.00]

0.857

1.00 [1.00–1.00]

0.420

1.00 [1.00–1.00]

0.127

Simvastatin

0.49 [0.32–0.75]

0.001

0.55 [0.37–0.83]

0.004

0.53 [0.37–0.78]

0.001

Statin dose

1.00 [1.00–1.00]

0.251

1.00 [1.00–1.00]

0.548

1.00 [1.00–1.01]

0.204

  1. LDL-C, low-density lipoprotein cholesterol; non HDL-C, non high-density lipoprotein cholesterol; Apo B, apolipoprotein B; ASCVD, atherosclerotic vascular disease; aOR, adjusted odds ratio; CI, confidence interval; BMI, body mass index; MetS, metabolic syndrome; TG, triglycerides
  2. The associations between LDL-C, non-HDL-C and ApoB goal attainment and sex were evaluated using multivariate logistic regression models adjusted for age, BMI, smoking status, MetS, baseline TG and LDL-C as well as statins prescribed (1 = simvastatin, 0 = atorvastatin and rosuvastatin) and the associated dose strengths of statins
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X